Entry - #613690 - CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7 - OMIM - (OMIM.ORG)
# 613690

CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
19q13.42 Cardiomyopathy, hypertrophic, 7 613690 AD 3 TNNI3 191044
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE - Autosomal dominant [SNOMEDCT: 263681008, 771269000] [UMLS: C1867440, C0443147 HPO: HP:0000006] [HPO: HP:0000006] CARDIOVASCULAR Heart - Ventricular hypertrophy [SNOMEDCT: 266249003] [UMLS: C0340279 HPO: HP:0001714] [HPO: HP:0001714] - Apical hypertrophy (in some patients) [UMLS: C3150947] - Ventricular preexcitation, Wolff-Parkinson-White (in some patients) [SNOMEDCT: 74390002] [ICD10CM: I45. 6] [UMLS: C0043202 HPO: HP:0001716] - Atrial fibrillation (in some patients) [SNOMEDCT: 164889003, 49436004] [ICD9CM: 427. 31] [UMLS: C2926591, C0004238, C0344434 HPO: HP:0005110] [HPO: HP:0005110] MISCELLANEOUS - Genetic heterogeneity (see 192600) [UMLS: C0242960] - Sudden cardiac death in some families MOLECULAR BASIS - Caused by mutation in the cardiac troponin I gene (TNNI3, 191044. 0001) ▲ Close Cardiomyopathy, familial hypertrophic - PS192600 - 38 Entries Location Phenotype Inheritance Phenotypemapping key PhenotypeMIM number Gene/Locus Gene/LocusMIM number 1p36. 11 Cardiomyopathy, familial hypertrophic, 31 AR 3 621270 TRIM63 606131 1p31. 1 Cardiomyopathy, hypertrophic, 20 AD 3 613876 NEXN 613121 1q32. 1 Cardiomyopathy, hypertrophic, 2 AD 3 115195 TNNT2 191045 1q43 Cardiomyopathy, dilated, 1AA, with or without LVNC AD 3 612158 ACTN2 102573 1q43 Cardiomyopathy, hypertrophic, 23, with or without LVNC AD 3 612158 ACTN2 102573 2q31. 2 . Cardiomyopathy, familial hypertrophic, 9 AD 3 613765 TTN 188840 3p25. 3 Cardiomyopathy, familial hypertrophic AD, DD 3 192600 CAV3 601253 3p21 VSports app下载. 31 Cardiomyopathy, hypertrophic, 8 AD, AR 3 608751 MYL3 160790 3p21. 1 Cardiomyopathy, hypertrophic, 13 AD 3 613243 TNNC1 191040 3q27. 1 Cardiomyopathy, familial hypertrophic, 29, with polyglucosan bodies AR 3 620236 KLHL24 611295 4p12 . Cardiomyopathy, familial hypertrophic, 30, atrial AR 3 620734 CORIN 605236 4q26 Cardiomyopathy, hypertrophic, 16 AD 3 613838 MYOZ2 605602 6q22. 31 Cardiomyopathy, hypertrophic, 18 AD 3 613874 PLN 172405 7p12. 1-q21 Cardiomyopathy, hypertrophic, 21 AD 2 614676 CMH21 614676 7q32. 1 Arrhythmogenic right ventricular dysplasia, familial AD 3 617047 FLNC 102565 7q32. 1 Cardiomyopathy, familial hypertrophic, 26 AD 3 617047 FLNC 102565 7q32. 1 Cardiomyopathy, familial restrictive 5 AD 3 617047 FLNC 102565 7q36. 1 Cardiomyopathy, hypertrophic 6 AD 3 600858 PRKAG2 602743 10q21. 3 Cardiomyopathy, familial restrictive, 4 AD 3 615248 MYPN 608517 10q21. 3 Cardiomyopathy, hypertrophic, 22 AD 3 615248 MYPN 608517 10q21. 3 Cardiomyopathy, dilated, 1KK AD 3 615248 MYPN 608517 10q22. 2 Cardiomyopathy, hypertrophic, 15 AD 3 613255 VCL 193065 10q23. 2 Cardiomyopathy, dilated, 1C, with or without LVNC AD 3 601493 LDB3 605906 10q23. 2 Cardiomyopathy, hypertrophic, 24 AD 3 601493 LDB3 605906 10q23. 2 Left ventricular noncompaction 3 AD 3 601493 LDB3 605906 11p15. 1 Cardiomyopathy, hypertrophic, 12 AD 3 612124 CSRP3 600824 11p11. 2 Cardiomyopathy, hypertrophic, 4 AD, AR 3 115197 MYBPC3 600958 12q24. 11 Cardiomyopathy, hypertrophic, 10 AD 3 608758 MYL2 160781 14q11. 2 Cardiomyopathy, hypertrophic, 14 AD 3 613251 MYH6 160710 14q11. 2 Cardiomyopathy, hypertrophic, 1 AD, DD 3 192600 MYH7 160760 15q14 Cardiomyopathy, hypertrophic, 11 AD 3 612098 ACTC1 102540 15q22. 2 Cardiomyopathy, hypertrophic, 3 AD 3 115196 TPM1 191010 15q25. 3 Cardiomyopathy, familial hypertrophic 27 AR 3 618052 ALPK3 617608 17q12 Cardiomyopathy, hypertrophic, 25 AD 3 607487 TCAP 604488 18q12. 2 Cardiomyopathy, familial hypertrophic, 28 AD 3 619402 FHOD3 609691 19q13. 42 Cardiomyopathy, hypertrophic, 7 AD 3 613690 TNNI3 191044 20q11. 21 Cardiomyopathy, hypertrophic, 1, digenic AD, DD 3 192600 MYLK2 606566 20q13. 12 Cardiomyopathy, hypertrophic, 17 AD 3 613873 JPH2 605267 ▲ Close ▼ TEXT A number sign (#) is used with this entry because of evidence that familial hypertrophic cardiomyopathy-7 (CMH7) is caused by heterozygous mutation in the TNNI3 gene (191044) on chromosome 19q13.

For a general phenotypic description and a discussion of genetic heterogeneity of familial hypertrophic cardiomyopathy (CMH), see CMH1 (192600).


Clinical Features

Kimura et al. (1997) identified 6 probands with hypertrophic cardiomyopathy and mutations in the TNNI3 gene VSports手机版. Three of these probands had ventricular hypertrophy characteristic of CMH; 3 others had apical hypertrophy (so-called Japanese-type CMH). The mutation-carrying son of one proband with apical hypertrophy had typical CMH. The 3 patients with apical hypertrophy carrying a G203S mutation (191044. 0014) also exhibited Wolff-Parkinson-White ventricular preexcitation (WPW; 194200). .

Niimura et al. (2002) presented data from a genetic analysis of 31 individuals with late-onset hypertrophic cardiomyopathy and no other family history V体育安卓版. They identified 2 individuals with CMH7. The mean age of symptom development was 52. 5 +/- 3. 6 with a mean age at diagnosis of 49. 0 +/- 9. 9. .

Arad et al. (2005) identified a proband with CMH7 with atrial fibrillation and apical cardiac hypertrophy. Five family members had undergone sudden cardiac death, and 3 additional mutation carriers in the family were found to have other CMH morphologies. In another family with the same mutation, the phenotype was primarily subaortic asymmetric hypertrophy. V体育ios版.


Inheritance

The transmission pattern of CMH7 in the families reported by Kimura et al. (1997) was consistent with autosomal dominant inheritance. VSports最新版本.


Molecular Genetics

Kimura et al. (1997) analyzed the TNNI3 gene in 184 unrelated patients with CMH and identified 6 heterozygous mutations in 6 probands, respectively (see, e. g V体育平台登录. , 191044. 0001 and 191044. 0002). Although apical CMH had been associated particularly with CMH4 (115197), Kimura et al. (1997) found that 3 of 36 (8. 3%) patients with apical CMH had mutations in the TNNI3 gene. In addition, all 3 individuals with the G203S mutation in the TNNI3 gene (191044. 0014) exhibited Wolff-Parkinson-White ventricular preexcitation (WPW; 194200); Kimura et al. (1997) noted that although a locus for 'CMH with WPW' had been mapped to chromosome 7q3 (CMH6; 600858), their findings indicated that more than one form of CMH is associated with WPW syndrome. .

Among 31 individuals with late-onset hypertrophic cardiomyopathy and no other family history, Niimura et al VSports注册入口. (2002) identified 2 individuals with pathogenic mutations in the TNNI3 gene. Both reported mutations (191044. 0003, 191044. 0004) were missense mutations in conserved residues. .

Arad et al. (2005) identified a heterozygous R21C mutation in the TNNI3 gene (191044 V体育官网入口. 0016) in 2 families with CMH. .


REFERENCES

Arad, M. , Penas-Lado, M VSports在线直播. , Monserrat, L. , Maron, B. J. , Sherrid, M. , Ho, C. Y. , Barr, S. , Karim, A. , Olson, T. M. , Kamisago, M. , Seidman, J. G. , Seidman, C. E. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112: 2805-2811, 2005. [PubMed: 16267253, related citations] [Full Text] .

  • Kimura, A. , Harada, H. , Park, J. -E. , Nishi, H. , Satoh, M. , Takahashi, M. , Hiroi, S. , Sasaoka, T. , Ohbuchi, N. , Nakamura, T. , Koyanagi, T. , Hwang, T. -H. , Choo, J. , Chung, K. -S. , Hasegawa, A. , Nagai, R. , Okazaki, O. , Nakamura, H. , Matsuzaki, M. , Sakamoto, T. , Toshima, H. , Koga, Y. , Imaizumi, T. , Sasazuki, T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy V体育2025版. Nature Genet. 16: 379-382, 1997. [PubMed: 9241277, related citations] [Full Text] .

  • Niimura, H., Patton, K. K., McKenna, W. J., Soults, J., Maron, B. J., Seidman, J. G., Seidman, C. E. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105: 446-451, 2002. [PubMed: 11815426, related citations] [Full Text]


  • Creation Date:
    Anne M. Stumpf : 1/13/2011
    carol : 12/15/2022
    carol : 09/22/2020
    alopez : 01/14/2011
    alopez : 1/14/2011
    alopez : 1/14/2011

    # 613690

    CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 7; CMH7 (VSports最新版本)


    DO: 0110313;   MONDO: 0013369;  


    Phenotype-Gene Relationships

    Location Phenotype Phenotype
    MIM number
    Inheritance Phenotype
    mapping key
    Gene/Locus Gene/Locus
    MIM number
    19q13.42 Cardiomyopathy, hypertrophic, 7 613690 Autosomal dominant 3 TNNI3 191044

    TEXT

    A number sign (#) is used with this entry because of evidence that familial hypertrophic cardiomyopathy-7 (CMH7) is caused by heterozygous mutation in the TNNI3 gene (191044) on chromosome 19q13.

    For a general phenotypic description and a discussion of genetic heterogeneity of familial hypertrophic cardiomyopathy (CMH), see CMH1 (192600).


    Clinical Features

    Kimura et al. (1997) identified 6 probands with hypertrophic cardiomyopathy and mutations in the TNNI3 gene. Three of these probands had ventricular hypertrophy characteristic of CMH; 3 others had apical hypertrophy (so-called Japanese-type CMH). The mutation-carrying son of one proband with apical hypertrophy had typical CMH. The 3 patients with apical hypertrophy carrying a G203S mutation (191044.0014) also exhibited Wolff-Parkinson-White ventricular preexcitation (WPW; 194200).

    Niimura et al. (2002) presented data from a genetic analysis of 31 individuals with late-onset hypertrophic cardiomyopathy and no other family history. They identified 2 individuals with CMH7. The mean age of symptom development was 52.5 +/- 3.6 with a mean age at diagnosis of 49.0 +/- 9.9.

    Arad et al. (2005) identified a proband with CMH7 with atrial fibrillation and apical cardiac hypertrophy. Five family members had undergone sudden cardiac death, and 3 additional mutation carriers in the family were found to have other CMH morphologies. In another family with the same mutation, the phenotype was primarily subaortic asymmetric hypertrophy.


    Inheritance

    The transmission pattern of CMH7 in the families reported by Kimura et al. (1997) was consistent with autosomal dominant inheritance.


    Molecular Genetics

    Kimura et al. (1997) analyzed the TNNI3 gene in 184 unrelated patients with CMH and identified 6 heterozygous mutations in 6 probands, respectively (see, e.g., 191044.0001 and 191044.0002). Although apical CMH had been associated particularly with CMH4 (115197), Kimura et al. (1997) found that 3 of 36 (8.3%) patients with apical CMH had mutations in the TNNI3 gene. In addition, all 3 individuals with the G203S mutation in the TNNI3 gene (191044.0014) exhibited Wolff-Parkinson-White ventricular preexcitation (WPW; 194200); Kimura et al. (1997) noted that although a locus for 'CMH with WPW' had been mapped to chromosome 7q3 (CMH6; 600858), their findings indicated that more than one form of CMH is associated with WPW syndrome.

    Among 31 individuals with late-onset hypertrophic cardiomyopathy and no other family history, Niimura et al. (2002) identified 2 individuals with pathogenic mutations in the TNNI3 gene. Both reported mutations (191044.0003, 191044.0004) were missense mutations in conserved residues.

    Arad et al. (2005) identified a heterozygous R21C mutation in the TNNI3 gene (191044.0016) in 2 families with CMH.


    REFERENCES

    1. Arad, M., Penas-Lado, M., Monserrat, L., Maron, B. J., Sherrid, M., Ho, C. Y., Barr, S., Karim, A., Olson, T. M., Kamisago, M., Seidman, J. G., Seidman, C. E. Gene mutations in apical hypertrophic cardiomyopathy. Circulation 112: 2805-2811, 2005. [PubMed: 16267253] [Full Text: https://doi.org/10.1161/CIRCULATIONAHA.105.547448]

    2. Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., Koyanagi, T., Hwang, T.-H., Choo, J., Chung, K.-S., Hasegawa, A., Nagai, R., Okazaki, O., Nakamura, H., Matsuzaki, M., Sakamoto, T., Toshima, H., Koga, Y., Imaizumi, T., Sasazuki, T. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy. Nature Genet. 16: 379-382, 1997. [PubMed: 9241277] [Full Text: https://doi.org/10.1038/ng0897-379]

    3. Niimura, H., Patton, K. K., McKenna, W. J., Soults, J., Maron, B. J., Seidman, J. G., Seidman, C. E. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 105: 446-451, 2002. [PubMed: 11815426] [Full Text: https://doi.org/10.1161/hc0402.102990]


    Creation Date:
    Anne M. Stumpf : 1/13/2011

    Edit History:
    carol : 12/15/2022
    carol : 09/22/2020
    alopez : 01/14/2011
    alopez : 1/14/2011
    alopez : 1/14/2011